| Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy E Auclin, A Zaanan, D Vernerey, R Douard, C Gallois, P Laurent-Puig, ... Annals of Oncology 28 (5), 958-968, 2017 | 131 | 2017 |
| Adjuvant chemotherapy for stage III colon cancer J Taieb, C Gallois Cancers 12 (9), 2679, 2020 | 72 | 2020 |
| Colorectal cancer: why does side matter? C Gallois, S Pernot, A Zaanan, J Taieb Drugs 78, 789-798, 2018 | 59 | 2018 |
| Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: current knowledge and future perspectives J Palle, A Rochand, S Pernot, C Gallois, J Taïeb, A Zaanan Drugs 80 (4), 401-415, 2020 | 54 | 2020 |
| Methylator phenotype in colorectal cancer: a prognostic factor or not? C Gallois, P Laurent-Puig, J Taieb Critical reviews in oncology/hematology 99, 74-80, 2016 | 51 | 2016 |
| Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study C Gallois, P Artru, A Lièvre, E Auclin, T Lecomte, C Locher, L Marthey, ... European journal of cancer 119, 35-43, 2019 | 39 | 2019 |
| Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized … M Karoui, C Gallois, G Piessen, JL Legoux, E Barbier, C De Chaisemartin, ... Colorectal Disease 23 (6), 1357-1369, 2021 | 35 | 2021 |
| Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy C Gallois, J Taieb, D Le Corre, K Le Malicot, J Tabernero, C Mulot, ... Clinical Cancer Research 24 (19), 4745-4753, 2018 | 32 | 2018 |
| Ulcerative colitis and electronic cigarette: what's the matter? M Camus, G Gallois, P Marteau Official journal of the American College of Gastroenterology| ACG 109 (4 …, 2014 | 20 | 2014 |
| Middle-term mortality and re-bleeding after initial diverticular bleeding: A nationwide study of 365 mostly elderly French patients D Lorenzo, C Gallois, P Lahmek, B Lesgourgues, C Champion, ... United European Gastroenterology Journal 5 (1), 119-127, 2017 | 18 | 2017 |
| Prognostic impact of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer: an ACCENT/IDEA pooled analysis of 11 adjuvant trials C Gallois, Q Shi, JP Meyers, T Iveson, SR Alberts, A De Gramont, ... Journal of Clinical Oncology 41 (4), 803-815, 2023 | 16 | 2023 |
| MSI colorectal cancer, all you need to know C Flecchia, A Zaanan, W Lahlou, D Basile, C Broudin, C Gallois, L Pilla, ... Clinics and Research in Hepatology and Gastroenterology 46 (9), 101983, 2022 | 16 | 2022 |
| Prognostic impact of early treatment discontinuation and early oxaliplatin discontinuation in patients treated with 6 months of oxaliplatin-based adjuvant chemotherapy for … C Gallois, Q Shi, JP Meyers, T Iveson, SR Alberts, A De Gramont, ... Journal of Clinical Oncology 40 (4_suppl), 11-11, 2022 | 14 | 2022 |
| Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: an AGEO prospective multicenter study C Gallois, C Bourillon, E Auclin, P Artru, A Lièvre, T Lecomte, C Locher, ... Clinics and research in hepatology and gastroenterology 45 (6), 101603, 2021 | 14 | 2021 |
| LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 … J Taieb, O Bouche, T André, E Barbier, P Laurent-Puig, J Bez, C Toullec, ... Annals of Oncology 33, S1390-S1391, 2022 | 11 | 2022 |
| Avelumab vs standard second-line chemotherapy in patients with metastatic colorectal cancer and microsatellite instability: a randomized clinical trial J Taïeb, O Bouche, T André, K Le Malicot, P Laurent-Puig, J Bez, ... JAMA oncology 9 (10), 1356-1363, 2023 | 10 | 2023 |
| Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study E Alouani, M Mercier, C Flecchia, E Auclin, A Hollebecque, T Mazard, ... ESMO open 8 (3), 101574, 2023 | 9 | 2023 |
| EUS-guided gastroenterostomy in malignant gastric outlet obstruction: A comparative study between first-and second-line approaches after enteral stent placement E Perez-Cuadrado-Robles, H Alric, A Aidibi, M Bronswijk, G Vanella, ... Cancers 14 (22), 5516, 2022 | 8 | 2022 |
| First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study C Gallois, E Hafliger, E Auclin, A Perret, C Coutzac, A Turpin, A Pellat, ... Digestive and Liver Disease 54 (5), 684-691, 2022 | 7 | 2022 |
| Endoscopic ultrasound-guided gastrojejunostomy as a rescue therapy for gastric outlet obstruction in a patient with multiple previous procedures E Pérez-Cuadrado-Robles, G Perrod, H Benosman, E Ragot, C Gallois, ... Endoscopy 53 (04), E143-E144, 2021 | 7 | 2021 |
